SEC Form 4 research
| Issuer | Cadrenal Therapeutics, Inc. |
|---|---|
| Tickers | CVKD |
| Reporting owners | 10 |
| Officers and directors | 1 |
| Last public filing | 2026-10-13 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-13 | 2026-10-09 | Pham Quang X | A | 200,000 | $0 | Not reported |
| 2026-10-13 | 2026-10-09 | Golden Lee Scott | A | 75,000 | $0 | Not reported |
| 2026-10-13 | 2026-10-09 | MURPHY JOHN RAYMOND | A | 75,000 | $0 | Not reported |
| 2026-10-13 | 2026-10-09 | Cole Jeffrey Scott | A | 150,000 | $0 | Not reported |
| 2026-10-13 | 2026-10-09 | WILSON GLYNN | A | 75,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.